Australia markets closed

Mytrex Health Technologies, Inc. (4431.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
28.10+0.25 (+0.90%)
At close: 02:58PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
250,876
1,292,969
1,471,549
291,623
1,023,640
-
Cost of revenue
244,956
1,100,624
1,232,145
251,482
395,124
-
Gross profit
5,920
192,345
239,404
40,141
628,516
-
Operating expenses
Research development
8,715
12,303
16,395
1,978
0
-
Selling general and administrative
37,743
294,250
310,737
53,652
188,658
-
Total operating expenses
46,458
262,904
286,267
55,619
188,510
-
Operating income or loss
-40,538
-70,559
-46,863
-15,478
440,006
-
Interest expense
1,387
6,241
5,242
1,576
1,462
-
Income before tax
-57,621
-57,182
-61,859
-13,598
441,157
-
Income tax expense
-2,091
1,108
7,102
450
89,565
-
Income from continuing operations
-55,530
-58,290
-68,961
-14,048
351,592
-
Net income
-54,999
-56,219
-91,901
-14,011
352,274
-
Net income available to common shareholders
-54,999
-56,219
-91,901
-14,011
352,274
-
Basic EPS
-2.72
-
-2.52
-0.38
10.97
0.29
Diluted EPS
-2.72
-
-2.52
-0.38
10.71
0.29
Basic average shares
36,535
-
36,536
36,535
32,106
30,966
Diluted average shares
36,536
36,506
36,536
36,535
32,898
-